Bhangui Prashant, Allard Marc Antoine, Vibert Eric, Cherqui Daniel, Pelletier Gilles, Cunha Antonio Sa, Guettier Catherine, Vallee Jean-Charles Duclos, Saliba Faouzi, Bismuth Henri, Samuel Didier, Castaing Denis, Adam René
*AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, Villejuif, France†Univ Paris-Sud, Villejuif, France‡Medanta Institute of Liver Transplantation and Regenerative Medicine, Medanta-The Medicity, Delhi, NCR, India§Inserm, Unité 935, Villejuif, France¶Inserm, Unité 785, Villejuif, France.
Ann Surg. 2016 Jul;264(1):155-63. doi: 10.1097/SLA.0000000000001442.
In compensated cirrhotics with early hepatocellular carcinoma (HCC-cirr), upfront liver resection (LR) and salvage liver transplantation (SLT) in case of recurrence may have outcomes comparable to primary LT (PLT).
An intention-to-treat (ITT) analysis comparing PLT and SLT strategies.
Of 130 HCC-cirr patients who underwent upfront LR (group LR), 90 (69%) recurred, 31 could undergo SLT (group SLT). During the same period, 366 patients were listed for LT (group LLT); 26 dropped-out (7.1%), 340 finally underwent PLT (group PLT). We compared survival between groups LR and LLT, LR and PLT, and PLT and SLT.
Feasibility of SLT strategy was 34% (31/90). In an ITT analysis, group LLT had better 5-yr/10-yr overall survival (OS) compared with group LR (68%/58% vs. 58%/35%; P = 0.008). Similarly, 5-yr/10-yr OS and disease-free survival (DFS) were better in group PLT versus group LR (OS 73%/63% vs. 58%/35%, P = 0.0007; DFS 69%/61% vs. 27%/21%, P < 0.0001). Upfront resection and microvascular tumor invasion were poor prognostic factors for both OS and DFS, presence of satellite tumor nodules additionally predicted worse DFS. Group SLT had similar postoperative and long-term outcomes compared with group PLT (starting from time of LT) (OS 54%/54% vs. 73%/63%, P = 0.35; DFS 48%/48% vs. 69%/61%, P = 0.18, respectively).
In initially transplantable HCC-cirr patients, ITT survival was better in group PLT compared with group LR. SLT was feasible in only a third of patients who recurred after LR. Post SLT, short and long-term outcomes were comparable with PLT. Better patient selection for the "resection first" approach and early detection of recurrence may improve outcomes of the SLT strategy.
在代偿期肝硬化合并早期肝细胞癌(HCC - 肝硬化)患者中,初始肝切除术(LR)以及复发时的挽救性肝移植(SLT)可能具有与原发性肝移植(PLT)相当的疗效。
进行一项意向性治疗(ITT)分析,比较PLT和SLT策略。
在130例接受初始LR的HCC - 肝硬化患者(LR组)中,90例(69%)复发,其中31例可接受SLT(SLT组)。同期,366例患者被列入肝移植名单(LLT组);26例退出(7.1%),340例最终接受PLT(PLT组)。我们比较了LR组与LLT组、LR组与PLT组以及PLT组与SLT组之间的生存率。
SLT策略的可行性为34%(31/90)。在ITT分析中,LLT组的5年/10年总生存率(OS)优于LR组(68%/58% 对 58%/35%;P = 0.008)。同样,PLT组的5年/10年OS和无病生存率(DFS)优于LR组(OS 73%/63% 对 58%/35%,P = 0.0007;DFS 69%/61% 对 27%/21%,P < 0.0001)。初始切除和微血管肿瘤侵犯是OS和DFS的不良预后因素,卫星肿瘤结节的存在还预示着更差的DFS。与PLT组相比,SLT组术后及长期预后相似(从肝移植时间开始计算)(OS 54%/54% 对 73%/63%,P = 0.35;DFS 48%/48% 对 69%/61%,P = 0.18)。
在初始可移植的HCC - 肝硬化患者中,PLT组的ITT生存率优于LR组。SLT仅在LR术后复发患者中的三分之一可行。SLT术后,短期和长期预后与PLT相当。更好地选择“先切除”方法的患者并早期发现复发可能会改善SLT策略的疗效。